company background image
LYMF

Multi Units Luxembourg SICAV - Lyxor MSCI Emu (DR)ETF SWX:LYMFE Stock Report

Last Price

€62.24

Market Cap

€0

7D

0.7%

1Y

16.4%

Updated

18 Mar, 2024

Data

Company Financials

Multi Units Luxembourg SICAV - Lyxor MSCI Emu (DR)ETF

SWX:LYMFE Stock Report

Market Cap: €0

LYMFE Stock Overview

No business description

LYMFE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Multi Units Luxembourg SICAV - Lyxor MSCI Emu (DR)ETF Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Multi Units Luxembourg SICAV - Lyxor MSCI Emu (DR)ETF
Historical stock prices
Current Share Price€62.24
52 Week High€62.61
52 Week Low€55.77
Beta0
1 Month Change3.65%
3 Month Change7.55%
1 Year Change16.42%
3 Year Change19.01%
5 Year Change36.49%
Change since IPO26.09%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

LYMFECH Capital MarketsCH Market
7D0.7%2.7%-0.3%
1Y16.4%48.2%5.0%

Return vs Industry: LYMFE underperformed the Swiss Capital Markets industry which returned 48.1% over the past year.

Return vs Market: LYMFE exceeded the Swiss Market which returned 5.4% over the past year.

Price Volatility

Is LYMFE's price volatile compared to industry and market?
LYMFE volatility
LYMFE Average Weekly Movement1.1%
Capital Markets Industry Average Movement2.9%
Market Average Movement3.4%
10% most volatile stocks in CH Market8.1%
10% least volatile stocks in CH Market1.7%

Stable Share Price: LYMFE has not had significant price volatility in the past 3 months.

Volatility Over Time: LYMFE's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/an/a

Multi Units Luxembourg SICAV - Lyxor MSCI Emu (DR)ETF Fundamentals Summary

How do Multi Units Luxembourg SICAV - Lyxor MSCI Emu (DR)ETF's earnings and revenue compare to its market cap?
LYMFE fundamental statistics
Market capn/a
Earnings (TTM)€0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LYMFE income statement (TTM)
Revenue€0
Cost of Revenue€0
Gross Profit€0
Other Expenses€0
Earnings€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did LYMFE perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.